Mark. S. Silverberg

Mark. S. Silverberg's AcademicInfluence.com Rankings

Mark. S. Silverberg

Biology

#12327

World Rank

#15796

Historical Rank

Microbiology

#733

World Rank

#807

Historical Rank

Immunology

#820

World Rank

#843

Historical Rank

biology Degrees

Download Badge

Biology

Mark. S. Silverberg's Degrees

PhD Microbiology Stanford University
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Mark. S. Silverberg Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mark. S. Silverberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (2012) (4007)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. (2005) (2917)
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene (2006) (2867)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease (2008) (2621)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci (2010) (2516)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications (2006) (2504)
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis (2007) (1825)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target (2015) (1329)
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (2011) (1315)
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease (2001) (820)
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease (2011) (747)
Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease (2008) (674)
Genome-wide association identifies multiple ulcerative colitis susceptibility loci (2010) (621)
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease. (2006) (618)
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study (2016) (555)
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. (2000) (532)
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis (2009) (512)
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility (2009) (498)
Common variants at five new loci associated with early-onset inflammatory bowel disease (2009) (479)
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. (2004) (346)
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis (2013) (339)
Association of host genome with intestinal microbial composition in a large healthy cohort (2016) (330)
Complex host genetics influence the microbiome in inflammatory bowel disease (2014) (313)
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. (2009) (268)
Inflammatory Bowel Disease Characteristics Among African Americans, Hispanics, and Non-Hispanic Whites: Characterization of a Large North American Cohort (2006) (264)
High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis (2014) (250)
IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis (2013) (234)
Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease (2018) (233)
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. (2010) (225)
Ulcerative colitis loci on chromosomes 1p36 and 12q15 identified by genome-wide association study (2008) (199)
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases (2015) (193)
Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. (2012) (186)
Deep Resequencing of GWAS Loci Identifies Rare Variants in CARD9, IL23R and RNF186 That Are Associated with Ulcerative Colitis (2013) (180)
Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. (2010) (177)
Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting (2020) (164)
HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants (2014) (164)
NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2 (2011) (162)
A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. (2009) (161)
Prevalence of CARD15/NOD2 Mutations in Caucasian Healthy People (2007) (156)
Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease (2015) (156)
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases (2007) (155)
A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci (2012) (148)
Relationship Between Proximal Crohn's Disease Location and Disease Behavior and Surgery: A Cross-Sectional Study of the IBD Genetics Consortium (2013) (144)
Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis (2009) (140)
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes (2018) (139)
Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn’s disease (2009) (133)
Cannabis use amongst patients with inflammatory bowel disease (2011) (132)
Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease (2015) (131)
Risk Factors for Low Bone Density in Crohn's Disease (2002) (129)
Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohn's Disease, and Ulcerative Colitis Patients (2013) (117)
Distinct and overlapping genetic loci in crohn's disease and ulcerative colitis: Correlations with pathogenesis (2011) (116)
Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease (2012) (115)
CARD15 and HLA DRB1 Alleles Influence Susceptibility and Disease Localization in Crohn's Disease (2004) (113)
Genetic variation in myosin IXB is associated with ulcerative colitis. (2006) (108)
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease (2013) (108)
A Population- and Family-Based Study of Canadian Families Reveals Association of HLA DRB1*0103 With Colonic Involvement in Inflammatory Bowel Disease (2003) (101)
Future directions in inflammatory bowel disease management. (2014) (101)
Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. (2017) (100)
Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. (2014) (100)
Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease (2012) (100)
A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition. (2016) (99)
Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype (2009) (99)
Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease (2007) (98)
Increased Intestinal Permeability is Associated with Later Development of Crohn's Disease. (2020) (94)
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis (2008) (93)
Defects in Nicotinamide-adenine Dinucleotide Phosphate Oxidase Genes NOX1 and DUOX2 in Very Early Onset Inflammatory Bowel Disease (2015) (92)
Development of an index to define overall disease severity in IBD (2016) (92)
Analyzing the Human Microbiome: A “How To” guide for Physicians (2014) (88)
A validated web‐based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables (2016) (86)
The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis (2012) (82)
Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine. (2013) (80)
Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn's Disease. (2016) (79)
Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior (2011) (79)
Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. (2015) (79)
Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease. (2016) (78)
Characterization of the Gut-Associated Microbiome in Inflammatory Pouch Complications Following Ileal Pouch-Anal Anastomosis (2013) (73)
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: An expert consensus report (2012) (71)
Higher Activity of the Inducible Nitric Oxide Synthase Contributes to Very Early Onset Inflammatory Bowel Disease (2014) (71)
Corrigendum: Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study (2009) (71)
Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases (2020) (71)
Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis. (2016) (70)
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. (2011) (70)
Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. (1998) (68)
The IBD International Genetics Consortium Provides Further Evidence for Linkage to IBD4 and Shows Gene‐Environment Interaction (2005) (67)
Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans. (2015) (67)
Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies (2021) (67)
Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population (2016) (64)
Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. (2011) (63)
Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease (2017) (63)
Granulocyte–Macrophage Colony-Stimulating Factor Autoantibodies: A Marker of Aggressive Crohn's Disease (2013) (61)
Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population‐based cohort (2013) (61)
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (61)
Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis. (2012) (60)
Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies (2001) (60)
Genetic sharing and heritability of paediatric age of onset autoimmune diseases (2015) (59)
Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. (2020) (57)
Protein-Tyrosine Phosphatase Sigma Is Associated with Ulcerative Colitis (2007) (55)
Serological response to mRNA COVID-19 vaccines in IBD patients receiving biological therapies (2021) (55)
Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group. (2020) (55)
Genetic Variation in the Familial Mediterranean Fever Gene (MEFV) and Risk for Crohn's Disease and Ulcerative Colitis (2009) (54)
Clinical, Serologic, and Genetic Factors Associated with Pyoderma Gangrenosum and Erythema Nodosum in Inflammatory Bowel Disease Patients (2014) (51)
DEVELOPMENT AND VALIDATION OF A TEST TO MONITOR ENDOSCOPIC ACTIVITY IN PATIENTS WITH CROHN'S DISEASE BASED ON SERUM LEVELS OF PROTEINS. (2019) (50)
Determinants of Intestinal Permeability in Healthy First-Degree Relatives of Individuals with Crohn's Disease (2015) (47)
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus. (2012) (47)
Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis (2016) (47)
A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF. (2016) (47)
A pleiotropic missense variant in SLC 39 A 8 is associated with Crohn ’ s disease and human gut microbiome composition Short Title : SLC 39 A 8 associated with CD and gut microbiome (2016) (46)
Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis (2018) (45)
Dietary Guidance for Patients with Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease. (2020) (44)
Ileal pouch symptoms do not correlate with inflammation of the pouch. (2014) (44)
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis (2015) (44)
Assessing disease activity in ulcerative colitis: Patients or their physicians? (2010) (43)
MODIFIED 2-STAGE ILEAL POUCH-ANAL ANASTOMOSIS RESULTS IN LOWER RATE OF ANASTOMOTIC LEAK COMPARED TO TRADITIONAL 2-STAGE SURGERY FOR ULCERATIVE COLITIS Short title : Anastomotic leak in 2-Stage IPAA for UC (2016) (42)
Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease (2012) (42)
Sa2031 Accelerated Clearance of Serum Infliximab During Induction Therapy for Acute Ulcerative Colitis is Associated With Treatment Failure. (2012) (41)
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis (2017) (40)
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC) (2007) (39)
Modified Two-stage Ileal Pouch-Anal Anastomosis Results in Lower Rate of Anastomotic Leak Compared with Traditional Two-stage Surgery for Ulcerative Colitis. (2016) (39)
Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis (2010) (39)
Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits. (2016) (38)
Predictors of Outcome in Ulcerative Colitis (2015) (38)
Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis. (2016) (37)
FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects (2018) (36)
Phenotype-Stratified Genetic Linkage Study Demonstrates that IBD2 Is an Extensive Ulcerative Colitis Locus (2006) (35)
Preoperative Anti–tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch–anal Anastomosis (2016) (34)
Higher Infliximab Levels Are Not Associated With an Increase in Adverse Events in Inflammatory Bowel Disease. (2018) (34)
IBD Genetic Risk Profile in Healthy First-Degree Relatives of Crohn's Disease Patients. (2016) (34)
OCTNs: will the real IBD5 gene please stand up? (2006) (33)
Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. (2021) (32)
Extended haplotype association study in Crohn’s disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3 (2013) (32)
Contribution of higher risk genes and European admixture to Crohn's disease in African Americans (2012) (32)
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2020) (31)
Inflamed ulcerative colitis regions associated to MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target. (2021) (31)
Phenotypic and Genotypic Characteristics of Inflammatory Bowel Disease in French Canadians: Comparison With a Large North American Repository (2009) (31)
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study (2021) (31)
Serum Antibodies Associated with Complex Inflammatory Bowel Disease (2013) (30)
Genetic effects on the commensal microbiota in inflammatory bowel disease patients (2019) (30)
Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study (2016) (28)
MAST3: a novel IBD risk factor that modulates TLR4 signaling (2008) (28)
Serological markers associated with disease behavior and response to anti‐tumor necrosis factor therapy in ulcerative colitis (2015) (27)
Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity (2018) (27)
Psychobiological Subtypes of Ulcerative Colitis: pANCA Status Moderates the Relationship Between Disease Activity and Psychological Distress (2006) (26)
Biomarkers as potential treatment targets in inflammatory bowel disease: A systematic review. (2015) (25)
Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. (2018) (24)
Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized Computed Tomography Scoring System (2018) (24)
Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn’s Disease (2016) (24)
Higher Rates of Dose Optimisation for Infliximab Responders in Ulcerative Colitis than in Crohn's disease. (2015) (24)
Attachment, Childhood Abuse, and IBD-related Quality of Life and Disease Activity Outcomes (2014) (23)
Common and rare variant prediction and penetrance of IBD in a large, multi-ethnic, health system-based biobank cohort. (2020) (23)
The Prevalence and Clinical Associations of Subclinical Sacroiliitis in Inflammatory Bowel Disease. (2018) (23)
Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy. (2014) (23)
Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group. (2021) (22)
Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease (2018) (22)
Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis (2010) (21)
Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis (2015) (21)
Genetics and innate and adaptive immunity in IBD. (2014) (20)
Progression and Management of Duodenal Neoplasia in Familial Adenomatous Polyposis: A Cohort Study. (2015) (20)
Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype (2016) (20)
Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population. (2012) (20)
Population‐based case‐control study of alpha 1‐antitrypsin and SLC11A1 in Crohn's disease and ulcerative colitis (2008) (20)
Sa2047 Association of Serum Infliximab and Antibodies to Infliximab to Long-Term Clinical Outcome in Acute Ulcerative Colitis (2012) (19)
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune mediated inflammatory diseases. (2022) (19)
Microbial Disruption of Autophagy Alters Expression of the RISC Component AGO2, a Critical Regulator of the miRNA Silencing Pathway (2015) (18)
Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. (2019) (17)
Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. (2019) (17)
Differential miRNA expression in ileal and colonic tissues reveals an altered immunoregulatory molecular profile in individuals with Crohn's disease versus healthy subjects. (2019) (17)
Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. (2019) (17)
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease (2022) (17)
Magnesium Metabolism Studies in Children with Chronic Inflammatory Disease of the Bowel (1985) (17)
BASIC-ALIMENTARY TRACT Genetic Variation in Myosin IXB Is Associated With Ulcerative Colitis (2006) (16)
Replication of genetic variation in the MYO9B gene in Crohn's disease. (2011) (16)
Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease (2017) (15)
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. (2021) (15)
Mediterranean-like dietary pattern associations with gut microbiome composition and sub-clinical gastrointestinal inflammation. (2022) (15)
An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29 (2008) (15)
Stricturing and Fistulizing Crohn’s Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease (2018) (15)
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007 fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study (2017) (15)
Prevalence of genetic variants associated with inflammatory bowel disease in a healthy First Nations cohort (2012) (15)
Genetics of inflammatory bowel disease: current status and future directions. (2006) (14)
Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease (2016) (14)
What do changes in inflammatory bowel disease management mean for our patients? (2012) (14)
Genetic Predictors of Benign Course of Ulcerative Colitis—A North American Inflammatory Bowel Disease Genetics Consortium Study (2016) (14)
Anti-microbial antibody response is associated with future onset of Crohn's disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk. (2021) (14)
The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn’s Disease (2018) (13)
Erratum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (Nature Genetics (2011) 43 (246-252)) (2011) (13)
Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis. (2020) (13)
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility (2022) (13)
Ileal pouch–anal anastomosis for ulcerative colitis: a Canadian institution’s experience (2017) (13)
The Unsolved Link of Genetic Markers and Crohn's Disease Progression: A North American Cohort Experience. (2019) (12)
Celiac Disease Detected by Pouch Biopsy of a Patient With Ileal Pouch–Anal Anastomosis (2011) (12)
Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn’s Disease (2016) (12)
Microbiome analysis – from technical advances to biological relevance (2014) (12)
Tu1327a Golimumab for Treatment of Moderate to Severe Anti-TNF Refaractory Crohn's Disease: Open Label Experience (2012) (11)
Genome-wide association study identifies five novel susceptibility loci for Crohn ' s disease and implicates a role for autophagy in disease pathogenesis (2009) (11)
Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn’s disease subjects (2020) (11)
COVID-19 Pandemic: Which IBD Patients Need to Be Scoped—Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal (2020) (11)
Hypothesis-free analysis of ATG16L1 demonstrates gene-wide extent of association with Crohn's disease susceptibility (2012) (10)
Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease (2021) (10)
Su1858 – Real-World Effectiveness and Safety of Vedolizumab and Anti-TNF in Biologic-Naive Ulcerative Colitis Patients: Results from the Evolve Study (2019) (10)
Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis. (2019) (10)
Time to revisit disease classification in IBD: is the current classification of IBD good enough for optimal clinical management? (2021) (10)
Association Between a Multi-Locus Genetic Risk Score and Inflammatory Bowel Disease (2013) (10)
Functional interaction of ERAP2 and HLA-B27 activates the unfolded protein response (2016) (10)
The impact of ulcerative colitis is greater in unmarried and young patients. (2007) (9)
Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis (2021) (9)
Clinical features and genetic risk of demyelination following anti-TNF treatment. (2020) (9)
Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment. (2020) (9)
P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn’s disease patients: results from the EVOLVE study (2019) (9)
Su1762 Clinical and Molecular Characterization of Medically Refractory Acute, Severe Colitis: Preliminary Results From the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) Immunochip Study (2013) (9)
Su1312 A Validated Web-Based Patient Communication Tool to Display Individualized Crohn's Disease Predicted Outcomes Based on Clinical, Serologic and Genetic Variables (2014) (8)
Patients with Low Drug Levels or Antibodies to a Prior Anti-TNF Are More Likely to Develop Antibodies to a Subsequent Anti-TNF. (2021) (8)
Inflammatory Bowel Disease-Gastroenterology Diamond Jubilee Review. (2018) (8)
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study (2017) (8)
Serum Analyte Profiles Associated With Crohn's Disease and Disease Location. (2021) (8)
Effect of inflammatory bowel disease therapies on immunogenicity of Mycobacterium paratuberculosis proteins (2014) (8)
Sequencing of over 100,000 individuals identifies multiple genes and rare variants associated with Crohns disease susceptibility (2021) (8)
Have Genomic Discoveries in Inflammatory Bowel Disease Translated into Clinical Progress? (2012) (8)
Intraepithelial lymphocytosis is a frequent finding in biopsies from ileal pouch-anal anastomoses. (2016) (7)
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials (2021) (7)
Attitudes toward genetic testing in patients with inflammatory bowel disease (2007) (7)
Downregulation of Expression of Xenobiotic Efflux Genes is Associated with Pelvic Pouch Inflammation in Ulcerative Colitis (2014) (7)
Association between the C3435T polymorphism of the MDR1 gene and Crohn's disease. (2006) (7)
Sa1816 – Elevated Fecal Calprotectin in Healthy First Degree Relatives of Patients with Crohn's Disease is Associated with Future Diagnosis of Crohn's Disease (2019) (7)
The time has come for NOD2/CARD15 testing for families with Crohn's disease: pro. (2005) (7)
Erratum: Genome-wide association identifies multiple ulcerative colitis susceptibility loci (2011) (6)
A role for CXCR3 ligands as biomarkers of post-operative Crohn's disease recurrence. (2021) (6)
TNFRSF1B Is Associated with ANCA in IBD (2016) (6)
Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease Activity (2019) (6)
Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin (2001) (6)
Advancing Early Identification of Axial Spondyloarthritis: An Interobserver Comparison of Extended Role Practitioners and Rheumatologists (2019) (6)
P789 Microbiome composition is altered in patients with IBD independent of endoscopic activity. (2017) (6)
Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing. (2020) (5)
Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response (2017) (5)
Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness (2018) (5)
Integrative analysis of colonic biopsies from inflammatory bowel disease patients identifies an interaction between microbial bile-acid inducible gene abundance and human Angiopoietin-like 4 gene expression. (2021) (5)
Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population (2019) (5)
Prevalence of NOD2/CARD15 mutations in pediatric IBD (2003) (4)
Sa1968 Post-Induction Adalimumab Drug Levels Predict Clinical and Laboratory Remission at Week 24 in Patients With Crohn's Disease (2016) (4)
Sa1248 Late Adult-Onset Inflammatory Bowel Disease Patients Require Surgery Earlier During Their Disease Course Compared to Early Adult-Onset Patients (2012) (4)
Corrigendum: Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants (2009) (4)
The Toronto Ibd Global Endoscopic Reporting (Tiger) Score: A Single, Easy To Use Endoscopic Score For Both Crohn's Disease And Ulcerative Colitis Patients. (2021) (4)
638 5-Aminosalicylate (5-ASA) Induced Nephrotoxicity in Inflammatory Bowel Disease (2013) (4)
760 Divergence in L4 Crohn's Disease: Jejunal, Not Esophagogastroduodenal Involvement, is Protective of L2 Disease Location, and a Risk for Stricturing Behavior and Multiple Abdominal Surgeries. Report From the NIDDK-IBDGC Registry (2010) (4)
Low bone mineral density (BMD) in Crohn's disease (CD) occurs independent of corticosteroid use (1998) (4)
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. (2022) (4)
Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn’s disease (2021) (4)
OP04 Vedolizumab intravenous is effective across multiple treatment targets in chronic pouchitis: Results of the randomised, double-blind, placebo-controlled EARNEST trial (2022) (4)
Medication Adherence in Inflammatory Bowel Disease in the Global ALIGN Study: Impact of Concerns and Perceived Necessity of Immunosuppressants, 5-Aminosalicylates, and Tumor Necrosis Factor Inhibitors: 1872 (2015) (3)
Defects in NADPH Oxidase Genes NOX 1 and DUOX 2 in Very Early Onset In fl ammatory Bowel Disease 65 66 67 68 (2015) (3)
439 - Toward Computer-Based Automated Mayo Score Classification in Ulcerative Colitis through Classical and Deep Machine Learning (2018) (3)
Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. (2022) (3)
The NOD2 insC Risk Allele is Associated With Poor Pouch Outcome Following IPAA in Patients With Ulcerative Colitis (UC) (2011) (3)
P311 Microscopic inflammation and myenteric plexitis at the margin of resection do not predict endoscopic recurrence in patients with Crohn's disease after ileocolic resection. (2017) (3)
96 – Increased Intestinal Permeability is a Predictor of Crohn's Disease Development in a Large Cohort of Asymptomatic First Degree Relatives (2019) (3)
Genotype-phenotype analysis across 130 422 genetic variants identifies RSPO3 as the first genome-wide significant modifier gene in primary sclerosing cholangitis (2016) (3)
Infliximab Induces Mucosal Healing in a Proximal to Distal Direction in Acute Ulcerative Colitis (2011) (3)
Treatment of severe hidradenitis Suppurativa and Fistulizing Crohn’s disease with Guselkumab (2022) (3)
Contribution of HLA class II genes to susceptibility to ulcerative colitis (UC) in a Canadian inflammatory bowel disease (IBD) population (1998) (3)
Associations between quantitative evaluation of bowel wall microvascular flow by contrast‐enhanced ultrasound and indices of disease activity in Crohn's disease patients using both bolus and infusion techniques (2019) (3)
T1745 A Prospective Multicenter Study of Outcomes and Predictors of Response in Severe Pediatric Ulcerative Colitis (2009) (3)
Colorectal cancer risk in patients with inflammatory bowel disease and Lynch syndrome (2010) (3)
6 thiopurine induced pancreatitis in inflammatory bowel disease : clinical features and genetic determinants (2014) (3)
(919): Cannabis use by patients with inflammatory bowel disease (2007) (2)
Expression Changes of Xenobiotic Efflux Genes Are Associated With Ileal Inflammation in the Pelvic Pouch of Individuals With Ulcerative Colitis (2011) (2)
86 Association of Environmental Exposures With the Composition and Diversity of the Human Gut Microbiome in Healthy First Degree Relatives (FDR) of Crohn's Patients (2016) (2)
A127 ANTI-TNF VS SURGICAL MANAGEMENT OF ABDOMINAL PHLEGMON IN CROHN’S DISEASE: A RETROSPECTIVE ANALYSIS (2018) (2)
Corrigendum: Phenotypic and Genotypic Characteristics of Inflammatory Bowel Disease in French Canadians: Comparison With a Large North American Repository (2010) (2)
Conducting Translational Gastrointestinal Research in the Era of COVID-19 (2020) (2)
Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis (2016) (2)
Erratum: Phenotypic and genotypic characteristics of inflammatory bowel disease in french canadians: Comparison with a large North American repository (Am J Gastroenterol (2009) 104 (2233-2240) (DOI: 10.1038/ajg.2009.267) (2010) (2)
Genotype/phenotype correlations and implications for clinical practice. (2008) (2)
Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease (2021) (2)
Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn’s disease patients (2021) (2)
Ulcerative Colitis Patients on Vedolizumab Lacking Response at Induction Phase Continue to Improve Over the First 6 Months of Treatment (2017) (2)
P502 Ulcerative colitis patients on vedolizumab lacking response at induction phase continue to improve over the first 6 months of treatment. (2017) (2)
593 Predictive Value of Basal Plasmacytosis on Clinical Relapse in Quiescent Ulcerative Colitis (2015) (2)
847v 18 New Crohn's Disease Susceptibility Genes and Loci Identified by the International IBD Genetics Consortium (2010) (2)
Challenges and Opportunities in IBD Clinical Trial Design. (2021) (2)
Identifying novel high-impact rare disease-causing mutations, genes and pathways in exomes of Ashkenazi Jewish inflammatory bowel disease patients (2020) (2)
AB0526 A novel approach to the early detection of axial spondyloarthritis in patients with inflammatory bowel disease: the implementation of an advanced practice physiotherapistled screening program (2013) (2)
Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index (2021) (2)
Tu1962 Looking Beyond Symptoms and Disease Activity to Define Disease Severity in Inflammatory Bowel Disease: Results of an IOIBD Specialist Panel (2016) (2)
CONTRIBUTION OF DLG5, MDR1, NOD1/CARD4 AND TLR4 TO PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE (2006) (2)
Tu1316 Dose Optimization of Infliximab Using Therapeutic Drug Monitoring Is More Effective Than Dose Optimization Based on Clinical Assessment Alone in Patients With Active Inflammatory Bowel Disease (2015) (2)
Tu1352 Use of Complementary Alternative Medicine for Inflammatory Bowel Disease Is Associated With Worse Adherence to Conventional Therapy (2015) (2)
High Infliximab Levels are not Associated with a Higher Risk of Infection in IBD Patients (2017) (2)
OC-010 Detailed analysis of ATG16L1 demonstrates gene-wide extent of association with crohn's disease susceptibility (2012) (1)
31 Putative Genetic Loci and Confirmation of Association in IBD (2010) (1)
Sa1870 USTEKINUMAB LEVELS DIFFERENTIATE PATIENTS WITH ENDOSCOPICALLY ACTIVE AND INACTIVE CROHN'S DISEASE AS DEFINED USING A SERUM BASED ENDOSCOPIC HEALING INDEX (2020) (1)
259 Specific Crohn's Disease (CD) Associated Risk Alleles Are Associated With the Composition of the Intestinal Microbiota in Healthy First Degree Relatives (FDR) of CD Subjects (2013) (1)
A9 BACTERIAL BILE SALT HYDROLASE GENE ABUNDANCE IS ASSOCIATED WITH RORC GENE EXPRESSION IN INTESTINAL MUCOSA OF INFLAMMATORY DISEASE PATIENTS (2020) (1)
203 Biomarkers Associated With Progressive Behaviour in Crohn's Disease (2010) (1)
Tu1299 Higher Adalimumab Drug Levels Are Associated With Clinical and Endoscopic Remission in Patients With Crohn's Disease (2015) (1)
Clinical and Genetic Markers of Disease Prognosis in Ulcerative Colitis (2011) (1)
The Future of Molecular Approaches to Inflammatory Bowel Disease (2012) (1)
A133 EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS: REAL-WORLD EXPERIENCE IN A TERTIARY IBD CENTRE (2018) (1)
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis (2023) (1)
O-0026: African and European genetic admixture in African American IBD patients (2008) (1)
Development and Validation of a Multi-marker Serum Test for the Assessment of Mucosal Healing in Crohnʼs Disease Patients: 600 (2017) (1)
Complex host genetics influence the microbiome in inflammatory bowel disease (2014) (1)
Introduction and Analysis 1: The genetic analysis of a complex disease (2002) (1)
Israel–Gaza conflict (2009) (1)
Sa1234 RNA-Seq Derived Whole Blood Gene Expression Signature As a Biomarker for Differential Diagnosis and Intestinal Inflammation in Inflammatory Bowel Disease (2014) (1)
Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases (2022) (1)
Tu1757 Intestinal Microbiota Is a Heritable Trait in Healthy Subjects (2014) (1)
Su1786 A PBMC-Derived microRNA Signature Differentiates Colonic Crohn's Disease from Ulcerative Colitis (2016) (1)
391 Two Novel Polysaccharide Antibodies (Anti-Laminarin and Anti-Chitin) Predict An Aggressive Crohn's Disease Phenotype and Improve Differentiation Between Crohn's Disease and Ulcerative Colitis (2008) (1)
African and European genetic admixture in African American IBD patients: O-0026. (2008) (1)
89 Ileal Pouch Symptoms Are Associated With Changes in Microbial Composition and Diversity Not Necessarily Related to Endoscopic Inflammation (2016) (1)
The ileoanal pouch: the next frontier in inflammatory bowel disease. (2021) (1)
Su1236 High Fecal Calprotectin Correlate With Active Colonic Disease but Not With Small Intestinal Crohn's Disease Activity (2015) (1)
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: the PROCTRIAL Consensus. (2022) (1)
Phenotypic concordance and time clustering of diagnosis in multiply affected ibd families : the IOIBD Multiplex Family Collaborative Project, phases I a II (2005) (1)
Genetics of inflammatory bowel disease: where are we? (2000) (1)
Sa1959 Concentrations of 6-Thioguanine Nucleotide Correlate With Both Infliximab and Adalimumab Levels in Patients With Inflammatory Bowel Disease on Combination Therapy (2016) (1)
207 A Novel Algorithm-Based Approach Using Clinical Parameters, Genetic and Serological Markers to Effectively Predict Aggressive Disease Behavior in Patients With Crohn's Disease (2010) (1)
Author Correction: Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel (2022) (1)
Age at Diagnosis of Crohnʼs Disease May Explain NOD2-Smoking Interactions: 1975 (2015) (1)
565 Appendectomy and Extensive Disease Are Independent Predictors of Colectomy in Ulcerative Colitis: Results From a Large Cross-Sectional Cohort (2013) (1)
New Insights Into the Genetic Basis for Variation in Crohn's Disease (CD) Phenotype in a Population-Based Study (2011) (1)
Tu1928 A Peripheral Blood Derived microRNA Signature Reveals Molecular Differences in Patients With Endoscopically Quiescent Crohn's Disease Versus Healthy Controls (2016) (1)
CONTRIBUTION OF SUSCEPTIBILITY GENES TO PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE: 204 (2005) (1)
A101 USTEKINUMAB LEVELS MEASURED DURING INDUCTION ARE ASSOCIATED WITH CLINICAL AND BIOCHEMICAL OUTCOMES AT WEEK 12 OF TREATMENT IN CROHN’S DISEASE (2020) (1)
A41 LOSS OF SATB2 EXPRESSION IN COLORECTAL CANCER IS ASSOCIATED WITH DURATION OF INFLAMMATORY BOWEL DISEASE (2020) (1)
Increased Frequency of Risk Alleles in a Cohort of Healthy First Degree Relatives of Crohn's Disease Patients – A Report From the Michael J. Howorth/CCFC GEM Project (2011) (1)
Mo1666 Inflammation and Symptoms of Pouchitis-Are They Correlated? (2012) (1)
Prediction of Treatment Response in Crohn’s Disease Patients Using Contrast Enhanced Ultrasound: A Pilot Study (2017) (1)
Tu1943 Higher Activity of the Inducible Nitric Oxide Synthase Contributes to Very Early Onset of Inflammatory Bowel Disease (2013) (1)
Mo1840 Impact of Age on Beliefs About and Adherence to Medications in Patients With Inflammatory Bowel Disease: Results From the ALIGN Study (2016) (1)
Phenotypic Predictors of Endoscopic Recurrence after Ileal Resection for Crohn'S Disease: An Niddk IBD Genetics Consortium Prospective Study (2017) (1)
Colonic Vascular Prominence From Superior Mesenteric Vein Occlusion (2019) (1)
Analysis of Inflammatory Bowel Disease-Associated Genetic Variants in a Healthy Manitoban First Nations Cohort (2011) (1)
Su1805 THE LONG-TERM CORTICOSTEROID SPARING EFFECT OF ANTI-TNF THERAPY IN A REAL WORLD CROHN'S DISEASE COHORT (2020) (1)
Interleukin-10 Receptor Gene Polymorphisms Associate with Early-Onset Inflammatory Bowel Disease (2011) (1)
Antibody and T cell responses to SARS-CoV-2 mRNA vaccines during maintenance therapy for immune-mediated inflammatory diseases (2022) (1)
706 – A Prominent Role for Chemokines, in Particular Cxcl9, As Biomarkers Associated with Post-Operative Crohn's Disease Recurrence (2019) (1)
257 – Higher Abundance of Bile Acid-Metabolizing Microbiota is Associated with Type of Disease, Biopsy Location and Mucosal Inflammation in Inflammatory Bowel Disease Patients (2019) (1)
A novel NFKB1 promoter polymorphism shows altered binding to nuclear proteins and increases risk for ulcerative colitis (2003) (1)
Preoperative exposure to anti-tumor necrosis factor therapy in ulcerative colitis patients undergoing ileal pouch-anal anastomosis (IPAA) is not associated with histological fibrosis: A case control study. (2019) (1)
DOP79 Biomarkers for IBD using OLINK Proteomics inflammation panel: Preliminary results from the COLLIBRI consortium (2022) (1)
Mo1324 Association of a Panel of Anti-Microbial Antibodies With Disease Behavior and Response to Anti-TNF Therapy in a Cohort of Patients With Ulcerative Colitis (2013) (0)
P269 Phenotypic predictors of endoscopic recurrence after ileal resection for Crohn's disease: an NIDDK IBD Genetics Consortium prospective study. (2017) (0)
P426 Supra-therapeutic infliximab levels are not associated with a higher risk of infection in IBD patients. (2017) (0)
A142 INTER-OBSERVER AGREEMENT AND THE ROLE OF EDUCATIONAL TRAINING ON THE ENDOSCOPIC SCORING OF CROHN’S DISEASE (2018) (0)
263 Characterization of the Tissue-Associated Microbiome in Active and Inactive IBD (2013) (0)
Mo1241 Patterns of Extraintestinal Manifestations in Ulcerative Colitis and Crohn's Disease: Results From a Large Cross-Sectional Cohort (2013) (0)
M1142 Phenotypic Variables Associated with Progression of Disease Behaviour in Crohn's Disease (2009) (0)
Tu1831 – Use of Drug-Tolerant Assays in Inflammatory Bowel Disease; What Does It Tell Us? (2019) (0)
1107 Gene Expression Profiles Associated with Lack of Response to Intravenous Corticosteroids in Children with Severe Ulcerative Colitis (2009) (0)
Mo1124 RNA-SEQ GENE EXPRESSION PROFILE REVEALS THAT DUOXA2 AND CCL11 GENES ARE ASSOCIATED WITH PROGRESSIVE RISK OF COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE PATIENTS (2020) (0)
A26 USE OF DRUG-TOLERANT ASSAYS IN INFLAMMATORY BOWEL DISEASE; WHAT DOES IT TELL US? (2019) (0)
Combined histo-endoscopic remission but not endoscopic healing alone in ulcerative colitis is associated with a mucosal transcriptional profile resembling healthy mucosa. (2022) (0)
761 MEGA-ANALYSIS REVEALS NOVEL GENETIC ASSOCIATIONS WITH EXTRAINTESTINAL MANIFESTATIONS IN IBD (2020) (0)
1050 Which Non-Invasive Disease Activity Index Should Be Used in Ulcerative Colitis? A Systematic Head-to-Head Psychometric Comparison (2009) (0)
Sa1602: DISEASE OUTCOMES AFTER SEGMENTAL RESECTION OF COLONIC CROHN'S DISEASE: A RETROSPECTIVE MULTICENTER STUDY. (2022) (0)
W1224 Genotypic Overlap Between Crohn's Disease (CD) and Ulcerative Colitis (UC) in a Large Cohort of Patients With Inflammatory Bowel Disease (IBD) (2010) (0)
Efficacy of infliximab therapy for severe ulcerative colitis: P-047. (2008) (0)
833 DIETS HIGH IN OMEGA AND PLANT-DERIVED FATS, AND LOWER DIETARY INTAKE OF ISOMALT ARE ASSOCIATED WITH ENDOSCOPIC REMISSION AFTER ILEAL RESECTION FOR CROHN'S DISEASE (2020) (0)
150: BIOMARKERS FOR IBD USING OLINK PROTEOMICS INFLAMMATION PANEL: PRELIMINARY RESULTS FROM THE COLLIBRI CONSORTIUM (2022) (0)
Sa1799 Evaluation of Location-Specific, Tissue-Associated Microbiota in the Ileal Pouch, Terminal Ileum and Colon in Inflammatory Bowel Disease (IBD) (2013) (0)
A biological pathway approach to disease association studies: Toll receptor pathway alleles and susceptibility to inflammatory bowel disease (2006) (0)
Tu1492: ILEAL MICROBIOME REMAINS LESS DIVERSE IN ENDOSCOPICALLY AND HISTOLOGICALLY INACTIVE CROHN'S DISEASE COMPARED TO ULCERATIVE COLITIS OR HEALTHY CONTROLS (2022) (0)
Tu1906 EQTL Analysis Identifies Novel Associations Between Genotype and Gene Expression in the Human Intestine (2012) (0)
M1151 Outcomes After Ileal Resection in Paediatric Crohn Disease: A 30 Year Single Center Experience (2008) (0)
Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients (2023) (0)
Mo1698 Clinical, Genetic and Serological Markers of Disease Behaviour in Colonic Inflammatory Bowel Disease (2012) (0)
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (0)
975 Novel Associations of Uncommon Crohn's Disease Risk Alleles With Higher Frequencies in the Ashkenazi Jewish Population (2013) (0)
A235 ILEAL MICROBIOME ALPHA DIVERSITY REMAINS LOWER IN ENDOSCOPICALLY AND HISTOLOGICALLY INACTIVE CROHN’S DISEASE COMPARED TO ULCERATIVE COLITIS OR HEALTHY CONTROLS (2022) (0)
Effect of diagnostic misclassification on the ability to detect linkage in inflammatory bowel disease (IBD) (2000) (0)
Mo1676 Life Events as a Predictor of Inflammatory Bowel Disease Activity and Quality of Life (2012) (0)
Outcome After Pelvic Pouch Surgery is Associated With Differences in the Microbiome as Characterized by 16s rRNA Pyrosequencing (2011) (0)
Mo1107 THE GEM PROJECT: CROHN'S DISEASE POLYGENIC RISK SCORE IS ASSOCIATED WITH PRECLINICAL INFLAMMATION IN ASYMPTOMATIC FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS (2020) (0)
Su1859 – Real-World Effectiveness and Safety of Vedolizumab and Anti-TNF in Biologic-Naive Crohn’s Disease Patients: Results from the Evolve Study (2019) (0)
322 Chromatin Accessibility Differences Between CD4 T-Cells From Inflamed or Non-Inflamed Regions of the Gut in Inflammatory Bowel Diseases (2016) (0)
X. Challenges update workgroups (2008) (0)
Mo1836 – Can Crohn’s Patients Be Accurately Phenotyped Based on Operative and Pathology Review At Time of Ileal Resection? (2019) (0)
Tu1744 The Relationship Between Common IBD-Associated Risk Alleles and Intestinal Permeability in a Cohort of Healthy First Degree Relatives of Individuals With Crohn's Disease (2013) (0)
Su1892 - Factors Associated with Intestinal Resection in Crohn's Disease Patients with Bowel Damage Progression as Assessed by Lemann Index (2018) (0)
ssociation of Trough Serum Infliximab to Clinical Outcome After Scheduled aintenance Treatment for Crohn ’ s Disease (0)
374 INFLAMED ULCERATIVE COLITIS REGIONS ASSOCIATED TO MRGPRX2-MEDIATED MAST CELL DEGRANULATION AND CELL ACTIVATION MODULES, DEFINING A NEW THERAPEUTIC TARGET (0)
Mo1486: MANAGEMENT OF POUCH NEOPLASIA: A CONSENSUS GUIDELINE FROM THE INTERNATIONAL ILEAL POUCH CONSORTIUM (2022) (0)
Measurement of Disease Activity of Pouchitis (2022) (0)
Existing Bowel Preparation Quality Scales Are Reliable in the Setting of Centralized Endoscopy Reading (2022) (0)
Mo1594: ILEAL INVOLVEMENT DEFINED BY THE MONTREAL CLASSIFICATION IN CROHN’S DISEASE IS ASSOCIATED WITH A DISTINCT MICROBIAL COMPOSITION IN ILEAL AND COLONIC MUCOSA (2022) (0)
P687 Genetic associations with high-grade dysplasia and colorectal cancer in patients with colonic inflammatory bowel disease: preliminary results from ImmunoChip using a targeted analytic approach (2013) (0)
Combination agents target early, late stages of allergy (2003) (0)
P297 The Toronto IBD Global Endoscopic Reporting (TIGER) Score and its Ability to Predict Outcomes Regarding Steroid and Biologic Use in Ulcerative Colitis and Crohn’s Disease Patients – A Construct Validation Study (2023) (0)
776 IDENTIFYING NOVEL HIGH-IMPACT RARE DISEASE-CAUSING MUTATIONS, GENES AND PATHWAYS IN EXOMES OF ASHKENAZI JEWISH INFLAMMATORY BOWEL DISEASE PATIENT (0)
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2020) (0)
Tu1929 Association of Macro/Micro Nutrients With Endoscopic Disease Activity in Patients With Inflammatory Bowel Disease Suggests Possible Protective Role for Dietary Components (2016) (0)
A181 HIGHER CUMULATIVE HISTOLOGIC INFLAMMATORY BURDEN SCORE IS ASSOCIATED WITH THE RISK OF DEVELOPMENT OF COLORECTAL NEOPLASIA IN ULCERATIVE COLITIS (2023) (0)
Sa482 MEGA-ANALYSIS REVEALS CLINICAL SEROLOGICAL AND GENETIC ASSOCIATIONS WITH EXTRAINTESTINAL MANIFESTATIONS IN IBD (2021) (0)
Vedolizumab for the Treatment of Chronic Pouchitis. (2023) (0)
124 Exome Analyses Identify Novel Inflammatory Bowel Disease-Associated Genetic Variants (2014) (0)
Sa1871 USTEKINUMAB LEVELS MEASURED DURING INDUCTION ARE ASSOCIATED WITH CLINICAL AND BIOCHEMICAL OUTCOMES AT WEEK 12 OF TREATMENT IN CROHN'S DISEASE (2020) (0)
Mo1121 TARGETED MUCOSAL TRANSCRIPTOMICS ANALYSIS REVEALS DIFFERENTIAL EXPRESSION OF CARNITINE, TRIMETHYLAMINE AND TRIMETHYLAMINE-N-OXIDE GENE PATHWAYS IN INFLAMMATORY BOWEL DISEASE (2020) (0)
Clinical Features and Treatment Outcomes in Hidradenitis Suppurativa With Fistulizing Crohn’s Disease: A Systematic Review (2022) (0)
Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients (2023) (0)
Evaluation of the Pouch Microbiome Using RT-PCR Identifies Specific Microbial Elements Associated With Outcome (2011) (0)
Future directions in inflammatory bowel disease management ☆ ded from h (2014) (0)
A108 EARLY ALBUMIN LEVEL IS ASSOCIATED WITH TIME TO COLECTOMY AND RE-ADMISSION RISKS IN HOSPITALIZED ULCERATIVE COLITIS PATIENTS STARTING INFLIXIMAB (2019) (0)
P671 An IL23R risk variant is associated with changes in CD4+ T-cell subsets in peripheral blood of Crohn's disease patients (2013) (0)
Mo1248 Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease (2014) (0)
Sa2039 Does Anti-TNF-Alpha Therapy Affect the Morphology of Crohn's Disease? (2012) (0)
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes (2018) (0)
Determinants of corticosteroid-resistance in severe pediatric ulcerative colitis: P-0038. (2009) (0)
780 HOST SEROREACTIVITY TO MICROBIAL ANTIGENS IS ASSOCIATED WITH FUTURE ONSET OF CROHN'S DISEASE INDEPENDENT OF GUT BARRIER FUNCTION, SUBCLINICAL INFLAMMATION, AND GENETIC RISK (2021) (0)
1105 Serum gASCA, Anti-L and Smoking Status Are Associated with Crohn's Disease-Like Phenotype After Pelvic Pouch Surgery for Ulcerative Colitis (2009) (0)
What Constitutes Frailty In Inflammatory Bowel Disease? (2020) (0)
Tu1708 Associations Between Host Transcription and the Intestinal Microbiome (2013) (0)
Su1216 Low Fecal Calprotectin Correlates With Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease (2015) (0)
P189 Prospective Validation Study Regarding Disease Complications of the Toronto IBD Global Endoscopic Reporting (TIGER) Score in Ulcerative Colitis and Crohn’s Disease Patients (2023) (0)
Su1778 – The Toronto IBD Global Endoscopic Reporting (Tiger) Score: A Single, Easy to Use Endoscopic Score for All IBD Patients (2019) (0)
acute ulcerative colitis clinical outcome for infliximab treatment in Trough serum infliximab : a predictive factor of (2009) (0)
Mo1506: LOWER SERUM CONCENTRATION OF SULFATED BILE ACIDS IS ASSOCIATED WITH PRIMARY SCLEROSING CHOLANGITIS INFLAMMATORY BOWEL DISEASE COMORBIDITY AND ADVANCED LIVER FIBROSIS (2022) (0)
168 GENE EXPRESSION ANALYSES IN THE PERIOPERATIVE ILEAL RESECTION PERIOD ILLUMINATE PATHOGENIC AND PROTECTIVE CROHN'S DISEASE CELL SUBSETS (2021) (0)
Su1017: MALE GENDER AND NON-CAUCASIAN ETHNICITY ARE ASSOCIATED WITH HIGHER RISK OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE INDEPENDENT OF KNOWN CLINICAL RISK FACTORS (2022) (0)
A221 CROHN’S DISEASE POLYGENIC RISK SCORE IS ASSOCIATED WITH FECAL CALPROTECTIN CONCENTRATION IN ASYMPTOMATIC FIRST-DEGREE RELATIVES OF CROHN’S DISEASE PATIENTS (2020) (0)
Mo1240 Do Genetic Markers Predict a Progressive Disease Course in Crohn's Disease? (2014) (0)
836 Genetic Associations With High-grade Dysplasia and Colorectal Cancer in Patients With Colonic Inflammatory Bowel Disease: Preliminary Results From Immunochip Using a Targeted Analytic Approach (2013) (0)
Sa1757 Autophagy Regulates Expression of the RISC Component Ago2 a Critical Regulator of the miRNA Silencing Pathway (2013) (0)
The Utility of Genetics in Classifying Ulcerative Colitis and Crohn's Disease Patients (2011) (0)
P009 Determinants of Corticosteroid-Resistance in Severe Pediatric Ulcerative Colitis (2009) (0)
Su1900 Association of Functional Capacity of Fecal Microbiota With Intestinal Permeability in Healthy First Degree Relatives of Crohn's Disease Patients (2016) (0)
108 – The Prevalence and Use of Cannabis by Patients with Inflammatory Bowel Disease (2019) (0)
Su1905 – B2 Stricturing Behavior Associated with TGF and Stromal Cell Survival Proteins in the Preoperative Period (2019) (0)
Mo1797 LOSS OF SATB2 EXPRESSION IN COLORECTAL CANCER IS ASSOCIATED WITH DURATION OF INFLAMMATORY BOWEL DISEASE (2020) (0)
P698 Characterization of the tissue-associated microbiome in active and inactive IBD (2013) (0)
P675 A locus on chromosome 8q24 near MYC and anti-OmpC are associated with perianal Crohn's disease (2013) (0)
P066 Lower serum concentration of sulfated bile acids is associated with Primary Sclerosing Cholangitis Inflammatory Bowel Disease comorbidity and advanced liver fibrosis (2022) (0)
P273 Prediction of treatment response in Crohn's disease patients using contrast enhanced ultrasound: a pilot study. (2017) (0)
P609 5-Aminosalicylate (5-ASA) induced nephrotoxicity in inflammatory bowel disease (2013) (0)
P050 Centrally-determined standardization of flow cytometry methods reduces inter-laboratory variation in a prospective multicenter study. (2017) (0)
584: VEDOLIZUMAB INTRAVENOUS IS EFFECTIVE ACROSS MULTIPLE TREATMENT TARGETS IN CHRONIC POUCHITIS: RESULTS OF THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EARNEST TRIAL (2022) (0)
A5 ASSOCIATION ANALYSIS BETWEEN BILE ACID-METABOLIZING MICROBIOTA ABUNDANCE AND ENDOSCOPIC INFLAMMATION IN INFLAMMATORY BOWEL DISEASE PATIENTS (2019) (0)
Tu1905 Interaction of IBD-Associated Genetic Polymorphisms and the Microbiome of the Pelvic Pouch (2012) (0)
Shorter Time Interval From Exposure to Biological Treatment to Surgery in Patients With IBD is Not Associated With Increased Short-Term Surgical Complications (2011) (0)
Sa1170 - Mir-874-3P Suppresses Atg16L1 In Vitro During Rapamycin Induced Autophagy (2018) (0)
744 Genome-Wide Association of Composition and Diversity of the Intestinal Bacterial Phyla in Healthy First Degree Relatives (FDR) of Crohn's Disease (CD) Subjects (2015) (0)
Increased Dietary Carbohydrate is Associated with Clinical Activity and with Endoscopic Remission in Inflammatory Bowel Disease (2017) (0)
P588 Interim results from the randomised VERDICT trial to determine the optimal treatment target in patients with ulcerative colitis (2023) (0)
Phenotypic variables associated with progression of disease behaviour In Crohnʼs Disease: P-0040. (2009) (0)
polymorphism in Lithuanian inﬂammatory patients associations with high-grade dysplasia and colorectal cancer in patients with colonic inﬂammatory bowel disease: preliminary results from ImmunoChip using a targeted analytic approach (2013) (0)
Su1884 Influence of the Microbiome on Epigenetic Mechanisms in Inflammatory Bowel Disease (IBD) (2016) (0)
Correction: Colonic Vascular Prominence From Superior Mesenteric Vein Occlusion. (2019) (0)
Tu1545: TRANS-CONTINENTAL ANALYSIS OF OVER 2,000 INFLAMMATORY BOWEL DISEASE PATIENTS IMPLICATES GEOGRAPHY, DISEASE TYPE, AND EXPOSURE TO IMMUNOSUPPRESSION AS DRIVERS OF SARS-COV-2 SEROPREVALENCE (2022) (0)
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn’s disease highlight earliest events of pathogenesis (2023) (0)
Genetic and environmental factors associated with diminished bone mineral density (BMD) differ in ulcerative colitis and Crohn's disease (2001) (0)
Diagnostic misclassification of patients with presumed inflammatory bowel disease (IBD) (2000) (0)
P342 Trans-continental analysis of over, 2000 Inflammatory Bowel Disease patients implicates geography, disease type, and exposure to immunosuppression as drivers of SARS-CoV-2 seroprevalence: data from the ICARUS-IBD Consortium (2022) (0)
P268 Development and validation of a novel composite index for the assessment of endoscopic and histologic disease activity in pouchitis: The Atlantic pouchitis index (2023) (0)
A66 CHARACTERIZATION OF PERIPHERAL BLOOD AND LAMINA PROPRIA LYMPHOCYTES IN CROHN’S DISEASE. (2018) (0)
Su1323 Patients With Crohn's Disease Who Never Smoke Are More Likely to Carry NOD2 Variants: A Case-Only NOD2-Smoking Interaction Study (2015) (0)
OP29 Peri-natal exposure to parental Crohn’s disease is associated with impaired gut barrier, microbiome composition differences and increased risk of Crohn’s disease (2023) (0)
Sa1733 - Higher Added Sugar and Lower Mono-Unsaturated Fat Intake is Associated with Post-Operative Crohn's Disease Recurrence after Ileal Resection: An Niddk IBD Genetics Consortium Prospective Study (2018) (0)
838 A Locus on Chromosome 8q24 Near MYC and Anti-OmpC Are Associated With Perianal Crohn's Disease (2013) (0)
Su1832 Sacroiliitis is underrecognized in Inflammatory Bowel Disease and is Associated With Previous Arthritis and Inflammatory Crohn's Phenotype (2016) (0)
Centrally-Determined Standardization of Flow Cytometry Methods Reduces Inter-Laboratory Variation in a Prospective Multicenter Study (2017) (0)
Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis (2021) (0)
W1226 Trough Serum Infliximab Predicts Outcome for Ulcerative Colitis Treatment with Infliximab (2008) (0)
P0128 PP CONTRIBUTION OF CARD15 AND IBD5 (5Q31) LOCI TO PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE (2004) (0)
Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's Disease. (2016) (0)
Tu1827 – Maintenance Levels of Vedolizumab Do Not Correlate with Clinical Remission in IBD Patients (2019) (0)
Mo1241 Has the Time to First Abdominal Surgery for Crohn's Disease Reduced With Early Immunosuppressant Therapy? (2014) (0)
DOP06 Histologic activity in Ulcerative Colitis patients achieving endoscopic healing is associated with higher rate of relapse and a distinct mucosal microbial and transcriptional profile (2021) (0)
Su1331 Stricturing/Penetrating Crohn's Disease at Diagnosis - Does It Predict an Aggressive Disease Course? (2015) (0)
P793 Microbial composition in IBD may influence clinical symptoms independent of endoscopic activity. (2017) (0)
University of Groningen Complex host genetics influence the microbiome in inflammatory bowel disease (2017) (0)
A236 ASSOCIATION OF STOOL METABOLOMIC PROFILE AND MICROBIOME COMPOSITION RISK SCORE WITH FUTURE ONSET OF CROHN’S DISEASE (2022) (0)
Su1893 - Patients with Persistently Clinically Silent Crohn's Disease can have Insidious, but Uneventful, Progression of Bowel Damage Due to small Bowel Stricturing as Assessed by Lemann Index (2018) (0)
P615 The unfinished symphony: golimumab is efficient in patients with refractory Crohn's disease. (2017) (0)
Tu1920 Predictors and Characteristics of Psoriasiform Skin Lesions While on Infliximab Among Patients With Inflammatory Bowel Disease (IBD) (2016) (0)
P310 Added value of anti CBir-1 antibodies to differentiate IBD unclassified from ulcerative colitis (2013) (0)
135 THE GEM PROJECT: DIETARY PATTERNS ARE ASSOCIATED WITH MICROBIOME COMPOSITION AND INTESTINAL INFLAMMATION IN HEALHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS (2020) (0)
Tu1548: IMMUNE RESPONSE AFTER COVID-19 VACCINATION DURING MAINTANACE THERAPY IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: AN OBSERVATIONAL COHORT STUDY (2022) (0)
A156 MUCOSA-ASSOCIATED MICROBIOTA OF ILEOCOLONIC CROHN’S DISEASE PATIENTS IS DISTINCT FROM COLONIC CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS INDEPENDENT OF BIOPSY SITE, ENDOSCOPIC INFLAMMATION AND HOST GENETICS (2022) (0)
Microbial Composition in IBD May Influence Clinical Symptoms Independent of Endoscopic Activity (2017) (0)
Tu1797 - Multi-Center Cohort Analysis Identified a Genetic Association in Complement Factor B with Perianal Crohn's Disease (2018) (0)
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2022) (0)
P700 Evaluation of location-specific, tissue-associated microbiota in the ileal pouch, terminal ileum and colon in inflammatory bowel disease (IBD) (2013) (0)
Infliximab induces mucosal healing in a proximal to distal direction in acute ulcerative colitis. (2011) (0)
The Interaction Between NOD2 and Smoking Is Specific to the 1007fs SNP of the NOD2 Gene in Crohnʼs Disease: A Systematic Review and Meta-analysis: 1979 (2015) (0)
A100 THE UNFINISHED SYMPHONY: GOLIMUMAB IS EFFICIENT AS SALVAGE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE (2018) (0)
Mo1117 INCREASED ABUNDANCE OF BACTERIAL BILE SALT HYDROLASE GENES IS ASSOCIATED WITH MUCOSAL RORγT GENE EXPRESSION IN INFLAMMATORY BOWEL DISEASE PATIENTS. (2020) (0)
555: MUCOSAL MICROBIAL PROFILES AT THE NEO-TERMINAL ILEUM ARE ASSOCIATED WITH FUTURE DEVELOPMENT OF POSTOPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE PATIENTS. (2022) (0)
P146 The Toronto IBD global endoscopic reporting (TIGER) score demonstrates significant correlation with fecal calprotectin, CRP and IBD Disk in Crohn’s disease patients (2021) (0)
Su1176 Added Value of Anti-Cbir-1 Antibodies to Differentiate IBD Unclassified From Ulcerative Colitis (2013) (0)
P-175 Pleiotropic Effects of Novel Functional LRRK2 Variation on Crohn's Disease and Parkinson's Disease Risk (2016) (0)
P688 Associations between host transcription and the intestinal microbiome (2013) (0)
Whole Genome Association Identifies Novel Susceptibility Genes for Crohn's Disease and Implicates a Crucial Role for Autophagy (2007) (0)
The future of molecular approaches to inflammatory bowel disease. (2009) (0)
Microrna Expression Patterns Associated with Tissue Location in Endoscopically Quiescent Crohn's Disease Versus Healthy Controls Suggest Alterations to Innate Immunological Response (2017) (0)
713f Histologic Activity in Ulcerative Colitis Patients Achieving Endoscopic Healing is Associated with Higher Rate of Relapse and a Distinct Mucosal Microbial and Transcriptional Profile (2021) (0)
P437 Higher adalimumab maintenance regimens are more effective than standard maintenance doses in Crohn’s disease patients who have failed infliximab (2018) (0)
Genetic susceptibility in a Canadian inflammatory bowel disease (IBD) population (1998) (0)
P690 Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis (2013) (0)
P223 C-reactive protein improvement after vedolizumab induction phase is associated with remission after 6 months of treatment in ulcerative colitis patients. (2017) (0)
A35 GENOME WIDE ASSOCIATION STUDY OF ABNORMAL INTESTINAL PERMEABILITY IN HEALTHY FIRST DEGREE RELATIVES OF CROHN’S PATIENTS (2018) (0)
A genome-wide scan in a canadian inflammatory bowel disease (IBD) population reveals two novel susceptibility loci (2000) (0)
Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease (2015) (0)
NADPH oxidase complex and IBD Candidate Gene studies: O-18. (2011) (0)
Su1269 Preoperative Anti TNF α Therapy in Ulcerative Colitis Patients Is Not Associated With an Increased Risk of Post Operative Ileal Pouch-Anal Anastomosis (IPAA) Leaks and Infectious Complications (2015) (0)
VI. Report of specific IBD diagnoses workgroup (2008) (0)
Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease. (2023) (0)
1025 Development of the Modified Harvey-Bradshaw Index (mHBI) Score, HBI-PRO, to Assess Disease Activity in Crohn's Disease (2015) (0)
S1173 Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Crohn's Disease (2010) (0)
Tu1264 Intolerance of Uncertainty and Quality of Life in Patients With Ulcerative Colitis (2015) (0)
A135 MICROBIOME IN CROHN’S DISEASE PATIENTS: A COMPILATION OF PUBLICLY AVAILABLE DATASETS (2018) (0)
Su1412 Is There a Higher Rate of Infliximab Dose Optimization in Initial Responders Between UC and CD Cases (2014) (0)
33 The GTPase RAC1 is Associated With Inflammatory Bowel Disease (2010) (0)
Identification of two novel susceptibility loci in a Canadian inflammatory bowel disease population (2000) (0)
A101 NO ASSOCIATION WITH RISK OF INFECTION IN IBD WITH HIGH SERUM INFLIXIMAB LEVELS (2018) (0)
694 Age Specific Genetic Variations in Very Early Onset Inflammatory Bowel Disease (2013) (0)
475 - Clinical Predictors of Recurrence after End Ileostomy and Colectomy for Crohn's Disease (2018) (0)
W1214 Genetic Polymorphisms, Serum Anti-Flagellin and ASCA are Associated With Outcome Following Ileal Pouch-Anal Anastomosis (IPAA) (2010) (0)
OP08 Mucosal healing with vedolizumab in inflammatory bowel disease patients with chronic pouchitis: Evidence from EARNEST, a randomized, double-blind, placebo-controlled trial (2023) (0)
S1213 Comparative Characteristics of Inflammatory Bowel Disease (IBD) in Individuals of South Asian, Jewish and Caucasian Ethnic Backgrounds (2010) (0)
Significance of fundic gland polyp carpeting in familial adenomatous polyposis (2003) (0)
Higher Adalimumab Maintenance Regimens Are More Effective Than Standard Maintenance Regimens in Crohnʼs Disease Patients Who Have Failed Infliximab: 745 (2017) (0)
Do Genes Matter (2017) (0)
P584 Efficacy, safety, and tolerability of AMT-101, a gut selective oral IL-10 fusion, in the Phase 2 FILLMORE trial of patients with chronic pouchitis (2023) (0)
DOP011 A genome wide association study identifying association of the MHC region with 5-aminosalicylate (5-ASA) induced nephrotoxicity in inflammatory bowel disease (2014) (0)
126 Fine Mapping the Association of IL23R SNPs With Microbiota Composition in Healthy Subjects (2014) (0)
Sa1866 LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF (2020) (0)
W1226 An IRGM Variant is Associated With Development of Anti-Microbial Antibodies in Crohn's Disease (2010) (0)
Abstracts of the 12th Congress of ECCO – European Crohn’s and Colitis Organisation S485 P791 Activation of the aryl hydrocarbon receptor after simvastatin and recombinant antagonist of receptors of interleukin-1 treatment in a rat model of inflammatory bowel disease (0)
P313 A composite serological panel predicts burden of inflammation in Crohn's disease (2013) (0)
DOP63 The Toronto IBD global endoscopic reporting (TIGER) score is well correlated with fecal calprotectin and IBD Disk in Ulcerative Colitis patients (2021) (0)
Mo1795 Environmental and Demographic Factors Are Associated With the Composition of Human Gut Microbiome in Healthy FDR of Crohn's Patients (2015) (0)
A88 A PROSPECTIVE STUDY OF MECHANISMS OF INTESTINAL INFLAMMATION AFTER ILEAL RESECTION IN CROHN’S DISEASE: PRELIMINARY ANALYSIS OF PHENOTYPIC PREDICTORS OF ENDOSCOPIC RECURRENCE (2018) (0)
Correction (2015) (0)
P708 Ileal involvement defined by Montreal classification in Crohn’s disease is associated with a distinct microbial composition in ileal and colonic mucosa (2022) (0)
Su1008 – Mir874-3P is Inversely Correlated with Its Target Atg16L1 in T-Cells of Inflammatory Bowel Disease Patients (2019) (0)
P899 Analysis of IL-23 receptor genetic variants associations with gut microbiome composition and barrier function in a cohort of healthy first-degree relatives of subjects with Crohn's disease (2023) (0)
Su1276 Use of Anti-TNF Therapy in Patients With Crohn's Disease Complicated by an Abdominal Phlegmon (2015) (0)
adherence with may CBir-1 antibodies to differentiate IBD unclassiﬁed from ulcerative colitis (2013) (0)
97 Detailed Analysis of ATG16L1 Demonstrates Gene-Wide Extent of Association With Crohn's Disease Susceptibility (2012) (0)
Mo1333 The Impact of Diet on Post-Operative Recurrence Following Ileal Resection in Crohn's Disease (2013) (0)
Mo1515: THE TRANSCRIPTOMIC PROFILE OF THE NON-INFLAMED ILEUM IN CROHN’S DISEASE DIFFERS COMPARED TO THAT OF HEALTH CONTROLS (2022) (0)
Persistent Symptoms, CRP Elevation and Treatment Changes Over Time in Crohn's Disease Patients are Associated with Bowel Damage Progression as Expressed by Deterioration of Lemann Index Score (2017) (0)
128 Evaluation of Genetic and Microbial Determinants of Intestinal Permeability in Healthy First Degree Relatives of Crohn's Disease (2014) (0)
P664 Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD (2023) (0)
Genetic Factors in the Pathogenesis of Inflammatory Pouch Disorders (2019) (0)
Sa1918 Better off Naïve: Predictors of Adalimumab Dose Escalation in Patients With Crohn's Disease (2012) (0)
P296 Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index score. (2017) (0)
P270 A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease (2023) (0)
Risk factors for bone loss in Crohn's disease (2000) (0)
Tu1758 Intestinal Microbiota Makeup Is Not Associated With NOD2 and FUT2 Genetic Polymorphisms in a Healthy Cohort (2014) (0)
A161 MUCOSAL TRANSCRIPTOMICS IN NON-INFLAMED ILEUM OF CROHN’S DISEASE PATIENTS SHOWS DIFFERENTIALLY EXPRESSED GENE PROFILE COMPARED TO ILEUM OF HEALTHY CONTROLS (2022) (0)
P700 The GEM Project: Stool metabolomic profile is associated with microbiome risk score and with future onset of Crohn’s disease in healthy first-degree relatives (2022) (0)
Su1751 Genetic Markers of Medically-Refractory Ulcerative Colitis and Proximal Disease Extension on Long-Term Follow-up – A Genome-Wide Association Study (2013) (0)
Sa.137. Toll-Like Receptor Pathway Polymorphisms and Association to Inflammatory Bowel Disease (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mark. S. Silverberg?

Mark. S. Silverberg is affiliated with the following schools:

Johns Hopkins University
University of Toronto
University of Pittsburgh

Mark. S. Silverberg's Academic­Influence.com Rankings

Mark. S. Silverberg's Degrees

Similar Degrees You Can Earn

Why Is Mark. S. Silverberg Influential?

Mark. S. Silverberg's Published Works

Published Works

What Schools Are Affiliated With Mark. S. Silverberg?

Mark. S. Silverberg's AcademicInfluence.com Rankings